Prostatic Neoplasms: all 6,484 studies
Page 42 of 65. Open to participants first (1,413), then studies with results posted, then the rest; newest registration first within each.
- Feasibility Trial in Men With Hormone Sensitive Oligometastatic Prostate CancerWithdrawnNCT03301701Not applicable
- Dynamics of Androgen Receptor Genomics and Transcriptomics After Neoadjuvant Androgen AblationCompletedNCT03297385Phase 2
- Prognostic Value of Androgen Receptor Expression and Mutations Within Oncogenes and Tumor Suppressor Genes in Patients Treated for High Risk Prostate Cancer With Proton Therapy (PRX32)WithdrawnNCT03296124
- Optimal Sequencing of Treatment Options for Poor Risk mCRPC Previously Treated With DocetaxelCompletedNCT03295565Phase 2/3
- Predictors of Normal Tissue Response From the Microenvironment in Radiotherapy for Prostate and Head-and-neck CancerStatus unknownNCT03294122
- MISOBOLD - Prostate Cancer Hypoxia Using BOLD MRI and 18F-MISO PET ImagingWithdrawnNCT03293602Not applicable
- Long-term Study to Evaluate and Clinical Outcomes in Patients With Favorable Intermediate Risk Localized Prostate CancerTerminatedNCT03290508
- Correlative Analysis of the Genomics of Vitamin D and Omega-3 Fatty Acid Intake in Prostate CancerCompletedNCT03290417Not applicable
- Dietary Factors and Racial Disparities in Prostate Cancer AggressivenessCompletedNCT03289130
- Cognitive Remediation Therapy (CRT) for Adults Treated for CancerCompletedNCT03285048Not applicable
- Kinetics of Perioperative Circulating DNA in Cancer SurgeryCompletedNCT03284684
- Exercise in Targeting Metabolic Dysregulation in Stage I-III Breast or Prostate Cancer SurvivorsTerminatedNCT03284346Not applicable
- Focused Stereotactic Radiation Treatment of Prostatic AdenocarcinomaStatus unknownNCT03284151
- Evaluation of a Web-based Decision Aid Tool for Prostate Cancer PatientsCompletedNCT03278197Not applicable
- Cisplatin in Castration Resistant Prostate CancerCompletedNCT03275857Early Phase 1
- Effect of Androgen Deprivation Therapy on Cardiovascular Function in Prostate CancerCompletedNCT03275181
- Effect of Ruxolitinib on Tumor Infiltrating Myeloid CellsWithdrawnNCT03274778Not applicable
- Effect of Anesthesia on Optic Nerve Sheath Diameter in Patients Undergoing Robot-assisted Laparoscopic ProstatectomyCompletedNCT03271502Not applicable
- Radiotherapy to the Prostate and Dominant Intra-Prostatic Lesion (DIL)CompletedNCT03269422Phase 1
- Smart After-Care in Patients With Prostate CancerStatus unknownNCT03264209Not applicable
- Study of Olaparib Maintenance Following Cabazitaxel-Carbo in Men With AVPCCompletedNCT03263650Phase 2
- Neoadjuvant Hiltonol® (PolyICLC) for Prostate CancerCompletedNCT03262103Phase 1
- Evaluation of a Blood Biomarker to Try and Distinguish Between the Presence or Absence of Aggressive Prostate CancerTerminatedNCT03256630
- Initial Experience in Brazilian Single Center With High Intensity Focalized Ultrasound (HIFU) Prostate Cancer Therapy: Morbidity, Oncological and Functional Outcomes.Status unknownNCT03255135Not applicable
- SPORT High-Risk Trial Evaluating SABR in Prostate CancerActive, not recruitingNCT03253978Not applicable
- Focal Prostate Imaging With CLE and OCTStatus unknownNCT03253458Not applicable
- Effects of High-intensity Training Compared to Resistance Training in Cancer Patients Undergoing RadiotherapyCompletedNCT03252821Not applicable
- Bone Marrow Suppression and Recovery During Radionuclide TreatmentCompletedNCT03247010
- Measurement of Natural Killer Cell Activity in Whole Blood in Men Being Screened for Prostate Cancer With BiopsyTerminatedNCT03242265Not applicable
- Vascular Changes Of Patients Undergoing Laparoscopic Radical ProstatectomyCompletedNCT03241758
- COHORT Trial in Clinical Pelivc Lymph Node Metastatic Prostate CancerActive, not recruitingNCT03241537Phase 3
- MR-simulation in Radiotherapy for Prostate CancerStatus unknownNCT03238170Not applicable
- Salvage Brachytherapy and Interstitial Hyperthermia for Locally Recurrent Prostate Carcinoma Following Radiation TherapyStatus unknownNCT03238066Not applicable
- Drug-drug-interaction Study to Assess the Effect of Darolutamide on the Pharmacokinetics of Probe Substrates of CYP3A4 and P-gp in Healthy Male VolunteersCompletedNCT03237416Phase 1
- Detection of ARv7 in the Plasma of Men With Advanced Metastatic Castrate Resistant Prostate Cancer (MCRP)SuspendedNCT03236688
- Decision Impact Trial of the ExoDx Prostate (IntelliScore)Status unknownNCT03235687Not applicable
- CyberKnife for Prostate Cancer Patients Aged 70 y or MoreCompletedNCT03235557
- Hypo-fractionated Postoperative IMRT in Prostate CancerCompletedNCT03233672Not applicable
- Extended Cancer Education for Longer-Term Survivors in Primary Care for Patients With Stage I-II Breast or Prostate Cancer or Stage I-III Colorectal CancerCompletedNCT03233555Not applicable
- Biobank for African American Prostate Cancer Research in FloridaCompletedNCT03232411
- PSMA-based 18F-DCFPyL PET/CT and PET/MRI Pilot Studies in Prostate CancerCompletedNCT03232164Early Phase 1
- Effect of Ramosetron on Heart Rate-corrected QT Interval During Robot-assisted Laparoscopic Prostatectomy With Steep Trendelenburg PositionCompletedNCT03232125Not applicable
- Sequencing of Radium-223 and Docetaxel in Symptomatic Bone-only Metastatic Castration-resistant Prostate CancerActive, not recruitingNCT03230734Phase 2
- Genetic Biomarker Discovery for Metastatic Prostate CancerCompletedNCT03228810
- Culture-guided Antimicrobial Prophylaxis in Men Undergoing Prostate Biopsy.CompletedNCT03228108Phase 4
- A Pilot Study of Prostate Cancer-specific Anxiety in Active SurveillanceTerminatedNCT03227744Not applicable
- MRI in PROstate Cancer Diagnosis With Prior Risk AssessmentCompletedNCT03225222
- Treatment Outcomes in a Non-study Population of Symptomatic mCRPC Patients Treated With Radium-223CompletedNCT03223727
- Registry of Treatment Outcomes of Symptomatic Metastasized Castration Resistant Prostate Cancer Treated With Radium-223CompletedNCT03223597
- Accuracy of Lymph Node Imaging in Prostate Cancer: PSMA PET-CT and Nano-MRIStatus unknownNCT03223064Not applicable
- Comprehensive Yoga Program (SKY) as Adjunct Therapy for Prostate CancerCompletedNCT03220945Not applicable
- Optical Tomography in Prostate CancerCompletedNCT03215992Not applicable
- Structural Network on Prostate Cancer in the French Greater West RegionCompletedNCT03214315
- Effect of Mannitol on Optic Nerve Sheath Diameter in Patients Undergoing Robotic ProstatectomyCompletedNCT03214055
- Ex-vivo Investigation of Beta Probe for Prostate Cancer Resection and Evaluation of PSMA-PET for Diagnosis of Intraprostatic LesionsCompletedNCT03213951
- Comparison of Duration of Treatment Interruption With or Without Curcumin During the Off Treatment Periods in Patients With Prostate Cancer Undergoing Intermittent Androgen Deprivation TherapyCompletedNCT03211104Not applicable
- A Study of Neoadjuvant TAK-700 and Leuprorelin Acetate Followed by Surgery Versus Surgery AloneTerminatedNCT03211052Phase 2
- Ga-68 PSMA Ligand: A Radiopharmaceutical for Localization of Prostate CancerCompletedNCT03207139Phase 2
- Adoption, Acceptability, and Effectiveness of a Mobile Health App for Personalised Prostate Cancer Survivorship Care.Status unknownNCT03207113Not applicable
- AZD5153 in Patients With Relapsed or Refractory Solid Tumors, Including LymphomasCompletedNCT03205176Phase 1
- PSMA PET Imaging of Recurrent Prostate CancerActive, not recruitingNCT03204123Phase 2
- Exercise During Active Surveillance for Prostate CancerCompletedNCT03203460Not applicable
- Phase IV Study to Evaluate Bone Mineral Density in No-bone Metastatic Prostate Cancer Treated With DegarelixStatus unknownNCT03202381Phase 4
- Evaluation of the Practice of the TEP Choline at Patients With Prostate CancerStatus unknownNCT03201380
- Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Treatment-Refractory Solid Tumor MalignanciesCompletedNCT03199586Phase 1
- Electronic Patient Reported Outcomes in Measuring Health-Related Quality of Life in Patients With Stage I-IV Prostate Cancer Undergoing TreatmentTerminatedNCT03197948
- Low Dose Hemi-body Radiation For Recurrent Prostate CancerCompletedNCT03196778Not applicable
- Enzalutamide and External Beam Hypofractionated Radiotherapy For Intermediate Risk Localized Prostate CancerStatus unknownNCT03196388Phase 2
- Ketogenic Diet and Prostate Cancer Surveillance PilotCompletedNCT03194516
- Observational Prospective Study Describing the Global Patient Care and Follow-up of Prostate Cancer Patients Treated With DegarelixCompletedNCT03193645
- A Multi-centre, Prospective, Observational Study on Effectiveness and Safety of ZOLADEX® (Goserelin Acetate Implant) 10.8 mg and ZOLADEX® (Goserelin Acetate Implant) 3.6 mg in Chinese Patients With Localized or Locally Advanced Hormonal Treatment -naïve Prostate CancerCompletedNCT03193060
- Prostate Cancer Survivors and Exercise and Behavioral CounselingCompletedNCT03191968Phase 2
- Positron Emission Tomography / Magnetic Resonance Imaging (PET/MRI) Guided Biopsy in Men With Elevated PSACompletedNCT03187990Not applicable
- Efficacy of Massage for the Treatment of Cancer-Related Fatigue (CRF) in Prostate Cancer SurvivorsCompletedNCT03187275Not applicable
- Dosimetry and Safety Phase 1 Study With 68Ga-PSMA-11 Sterile Cold KitCompletedNCT03183544Phase 1
- 18F-DCFPyL PET/CT in High Risk and Recurrent Prostate CancerActive, not recruitingNCT03181867Phase 2
- Integration of Cancer Health Activities Into African American ChurchesCompletedNCT03178383Not applicable
- Living With Prostate Cancer (LPC)CompletedNCT03177759
- Intimacy and Mindfulness Post-Prostate Cancer TreatmentCompletedNCT03177707Not applicable
- Predictive Nomogram of CRPCStatus unknownNCT03177551
- Daratumumab or FMS Inhibitor JNJ-40346527 Before Surgery in Treating Patients With High-Risk, Resectable Localized or Locally Advanced Prostate CancerCompletedNCT03177460Phase 1
- Combination Study of AZD5069 and Enzalutamide.TerminatedNCT03177187Phase 1/2
- Tissue Predictors of Abiraterone BenefitCompletedNCT03176381
- The Value of PSMA-PET Compared With Multi-parametric MRI in the Detection Prostate LesionsStatus unknownNCT03174054
- 18F-DCFPyL PSMA- Versus 18F-NaF-PET Imaging for Detection of Metastatic Prostate CancerActive, not recruitingNCT03173924Phase 2
- Efficacy of Rotations Between Abiraterone Acetate and Apalutamide in mCRPC PatientsWithdrawnNCT03173859Phase 2
- Combined, Intensified and Modulated Adjuvant Therapy in Prostate CarcinomaCompletedNCT03169933Not applicable
- 68Ga-NOTA-RM26 PET/CT in Prostate Cancer PatientsStatus unknownNCT03164837Phase 1
- Experiences With HDR-brachytherapy in NorwayCompletedNCT03162523
- Irish Programme for Stratified Prostate Cancer TherapyCompletedNCT03162003
- Prostate Cancer Subclinical Metastatic Ablative MR-guided RadiotherapyCompletedNCT03160794Not applicable
- Innovative Planning and Guidance System for Prostate Focal BrachytherapyCompletedNCT03160365Not applicable
- Proton-Based Stereotactic Ablative Body Radiotherapy for Prostate CancerCompletedNCT03159676
- The BARCODE 1 Pilot StudyActive, not recruitingNCT03158922
- Culturally Tailored Decision Aid for Hispanic Patients Diagnosed With Prostate CancerWithdrawnNCT03157947Not applicable
- Prospective Prolaris Value and EfficacyTerminatedNCT03152448
- UNDISTORT Correction of Distortions in Diffusion MRI V1.0CompletedNCT03151512
- Prostate Health Index for Prostate Cancer DiagnosisCompletedNCT03151356
- Detection of Clinically Significant Prostate Cancer With 18F-DCFPyL PET/MRCompletedNCT03149861Not applicable
- Technology Based Psychosocial Intervention for Symptom Management and HRQOL in Men Living With Advanced Prostate CancerCompletedNCT03149185Not applicable